- Starting October 1, in recognition of Breast Cancer Awareness Month, a portion of every BITS™ edibles purchased at hundreds of dispensaries in eight states will go directly to the Lynn Sage Breast Cancer Foundation, helping fund critical research and support for those impacted1
- Since 2021, Verano has collaborated with the Lynn Sage Breast Cancer Foundation to generate more than $250,000 in proceeds, and this year cannabis consumers have the opportunity to enjoy their favorite BITS™ edibles while supporting the cause
- Supporters can use the hashtag #SaveTheBits on social media for a chance to win a custom Save the Bits t-shirt, which will also be available for sale at participating Verano retail dispensary locations
CHICAGO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today launched “Save the Bits,” a fundraising campaign that will donate a portion of proceeds from sales of Verano’s BITS™ edibles across hundreds of cannabis dispensaries in eight states for Breast Cancer Awareness Month benefitting the Lynn Sage Breast Cancer Foundation.
Beginning October 1st and throughout the entire month, a portion of sales from each package of specially marked BITS™ edibles sold at dispensaries in eight states will be donated to the Lynn Sage Breast Cancer Foundation to advance their ongoing mission to fight and eradicate breast cancer. Packages of BITS™ will include a “Save the Bits” sticker to support the cause, and include a QR code linking to more information and education on the campaign’s mission. Additionally, “Save the Bits” will be supported with in-store and digital education elements to provide further awareness of this important cause across 225 dispensaries in eight states – comprised of 134 of the Company’s Zen Leaf and MÜV dispensaries and 91 participating third-party dispensaries.
Along with Verano’s Zen Leaf and MÜV dispensaries, nearly 40 third-party cannabis companies are participating in the Save the Bits campaign through in-store and digital activations in Arizona, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, and Pennsylvania.
"The Lynn Sage Breast Cancer Foundation is honored to partner with BITS™ to fund cutting-edge breast cancer trials that are accessible to a diverse group of patients. We are grateful for their generosity and continued support of the 1:8 women diagnosed with breast cancer," said Laura Sage, Executive Director of the Lynn Sage Breast Cancer Foundation.
“We are thrilled to launch the Save the Bits campaign in partnership with our peers in the cannabis community to benefit the Lynn Sage Breast Cancer Foundation,” said George Archos, Verano Founder and Chief Executive Officer. “Save the Bits is a powerful demonstration of the cannabis industry’s ability to deliver positive benefits for communities and important causes across the country, and we’re proud to stand together and support the fight against Breast Cancer throughout October.”
BITS™, Verano’s low-dose, high-function edibles brand that allow consumers to do more with less, are available in five different flavors combining 5 mg of THC with tailored cannabinoid ratios and adaptogens.
For more information about the Save the Bits campaign, visit www.bits.verano.com/savethebits. For more information about the Lynn Sage Breast Cancer Foundation, visit www.lynnsage.org.
About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, MÜV™, (the) Essence™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 14 markets, 15 production facilities, and over 1,100,000 square feet of cultivation capacity. Learn more at www.verano.com.
About Lynn Sage Breast Cancer Foundation
The Lynn Sage Breast Cancer Foundation’s mission is to raise funds for research and education to prevent breast cancer and improve outcomes for individuals with breast cancer. Investments are directed locally within the Chicago area but drive impact globally. The Lynn Sage Breast Cancer Foundation is one of the nation’s leading breast cancer research and education charities. Since 1985, this organization has raised over $40 million for breast cancer research & education advancements. Since the beginning, when Lynn’s dear friends and family established a foundation with a vow to cure this devastating disease, until now, they are dedicated to ending breast cancer.
Contacts:
Media
Verano
Grace Bondy
Senior Manager, Communications
Grace.Bondy@verano.com
Investors
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
Julianna.Paterra@verano.com
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2023 and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
1Visit Save the Bits for more information and disclaimers.
